⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MGX News
Metagenomi, Inc. Common Stock
Form 8-K
sec.gov
MGX
Metagenomi Therapeutics Reports Business Updates and Full Year 2025 Financial Results
globenewswire.com
MGX
Metagenomi Therapeutics Reports Business Updates and Full Year 2025 Financial Results
globenewswire.com
MGX
SuppCo Launches TESTED by SuppCo, an Independent Certification Program to Set New Standards for Trust and Transparency in the Supplement Industry
businesswire.com
MS
THO
MGX
GAIA
DFH
Metagenomi Therapeutics, Inc. to Present at the 46th Annual TD Cowen Healthcare Conference
globenewswire.com
MGX
Metagenomi Announces Corporate Name Change to Metagenomi Therapeutics, Inc. and Highlights Recent Business Milestones and 2026 Corporate Outlook
globenewswire.com
MGX
Metagenomi to Present Preclinical Data Supporting New Collaboration Target of APOC3 with Ionis Pharmaceuticals at Upcoming Nature Conference
globenewswire.com
MGX
Metagenomi to Present at Jefferies Global Healthcare Conference in London
globenewswire.com
MGX
Metagenomi Reports Third Quarter 2025 Financial Results and Announces Strategic Pipeline Prioritization and Leadership Updates
globenewswire.com
MGX
Metagenomi Presents New Preclinical Data from MGX-001 Hemophilia A Program Supporting Advancement into Clinical Development
globenewswire.com
MGX